8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Biologic effects of SMF and paclitaxel on K562 human leukemia cells

Bioeffects Seen

Authors not listed · 2012

Share:

Static magnetic fields made cancer drugs five times more effective by increasing cell membrane permeability and DNA damage.

Plain English Summary

Summary written for general audiences

Researchers exposed human leukemia cells to static magnetic fields (8.8 mT) combined with the cancer drug paclitaxel. The magnetic field dramatically enhanced the drug's effectiveness, requiring only one-fifth the normal dose to achieve the same cancer-fighting results. The combination caused more DNA damage and cellular changes than either treatment alone.

Why This Matters

This study reveals something remarkable: static magnetic fields can amplify the effects of cancer drugs by making cell membranes more permeable. The 8.8 mT field strength used here is roughly 160 times stronger than Earth's magnetic field, but still within the range of some medical MRI machines and industrial equipment. What's particularly striking is the five-fold increase in drug potency when combined with the magnetic field.

While this research focuses on beneficial applications for cancer treatment, it raises important questions about how magnetic fields interact with our cellular processes. The fact that magnetic fields can alter cell membrane permeability and enhance chemical effects suggests our cells are more responsive to magnetic environments than many realize. This isn't about everyday EMF exposure levels, but it demonstrates the biological reality that magnetic fields can produce measurable cellular changes.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2012). Biologic effects of SMF and paclitaxel on K562 human leukemia cells.
Show BibTeX
@article{biologic_effects_of_smf_and_paclitaxel_on_k562_human_leukemia_cells_ce4225,
  author = {Unknown},
  title = {Biologic effects of SMF and paclitaxel on K562 human leukemia cells},
  year = {2012},
  doi = {10.4149/gpb_2012_002},
  
}
DOI: 10.4149/gpb_2012_002PubMed: 22447825

Quick Questions About This Study

Yes, this study found that 8.8 mT static magnetic fields increased paclitaxel's effectiveness five-fold against leukemia cells. The required drug concentration dropped from 50 ng/ml to just 10 ng/ml when combined with the magnetic field.
The magnetic fields appear to increase cell membrane permeability, allowing more of the cancer drug to enter cells. This enhanced penetration leads to greater DNA damage and more effective cell cycle arrest in cancer cells.
Cells showed increased DNA damage, arrest in the G2 phase of cell division, altered surface structure with holes and protuberances, and increased vacuoles in the cytoplasm compared to either treatment alone.
No, 8.8 mT is approximately 160 times stronger than Earth's magnetic field and much higher than typical household exposures. This strength is more comparable to certain medical devices or industrial magnetic equipment.
The study showed magnetic fields alone had some effect, but the combination with paclitaxel was significantly more potent than either treatment individually, suggesting synergistic rather than purely additive effects.